Key result
Glycated albumin offers a promising alternative to HbA1c for faster glycaemic monitoring in specific populations.
Why the study?
Does glycated albumin monitoring improve glycaemic control assessment compared to HbA1c in diabetic patients?
Population
Diabetic patients, including those scheduled for surgery, pregnant, or with renal or haematologic…
Comparison
Glycated albumin (GA) monitoring vs HbA1c monitoring
Design
Review
Authors
Loading...
May warrant consideration where HbA1c is unreliable; leaves open need for prospective trials before routine adoption.
Does glycated albumin monitoring improve glycaemic control assessment compared to HbA1c in diabetic patients?
Glycated albumin may serve as a more accurate and rapidly responsive alternative to HbA1c for monitoring glycaemic control, particularly in patients with conditions that alter HbA1c concentrations.
Cichocka et al. (2017) conducted a review in Diabetes. Alternative biomarkers (Glycated albumin, Fructosamine) vs. HbA1c was evaluated. Glycated albumin serves as a promising alternative to HbA1c for glycaemic monitoring, offering faster detection of metabolic changes and greater accuracy in specific patient populations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: